logo
search
  • Products
    • Our products
      • Arazlo

        (tazarotene) Lotion, 0.045%

      • Duobrii

        (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045%

      • Altreno

        (tretinoin) Lotion, 0.05%

      • Jublia

        (efinaconazole) Topical Solution, 10%

      • Cabtreo

        (clindamycin phosphate, adapalene, and benzoyl peroxide) Topical Gel, 1.2%/0.15%/3.1%

      • Siliq

        (brodalumab) Injection, 210 mg/1.5 mL

        See full Prescribing Information, including Boxed Warning
        about suicidal ideation and behavior.

    • pipeline
  • Conditions
    • Featured conditions
      • Acne vulgaris
      • Plaque psoriasis
      • Onychomycosis (TOENAIL fungus)
      • Cutaneous t-cell lymphoma (ctcl)
      • Cold sores (herpes simplex virus)
      • Atopic dermatitis (eczema)
  • Resources
    • Resource Hub
    • Provider resources
    • Patient resources
    • Support & savings
    • Derm Locator
  • Scholarships
  • About
    • Who we are
    • Careers
    • Responsibility
    • Location
icon
savings
search
banner banner

YOU ARE HERE: HOME / RESOURCE HUB / PROVIDER RESOURCES

HOME / RESOURCE HUB / PROVIDER RESOURCES

Provider
resources

You can find prescribing information, product options, savings, support, and education here and on the below provider websites.

altreno

ALTRENO® (tretinoin) Lotion, 0.05%

FULL PRESCRIBING
INFORMATION

Find resources designed to help you make informed decisions for your patients.

Provider Website
arazlo

ARAZLO® (tazarotene) Lotion, 0.045% 

FULL PRESCRIBING
INFORMATION

Explore clinical data to help guide informed treatment decisions.

Provider Website
cabtreo

CABTREO® (clindamycin phosphate, adapalene, and benzoyl peroxide) Topical Gel, 1.2%/0.15%/3.1%

FULL PRESCRIBING
INFORMATION

Download the Prior Authorization Request Letter and Letter of Medical Necessity to help patients access CABTREO. If coverage is denied, your practice may need to file an appeal and submit these forms to show medical necessity and support insurance approval.

Provider Website
  • letter of medical necessity
  • PRIOR AUTHORIZATION FORM
duobrii

DUOBRII® (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045% 

FULL PRESCRIBING
INFORMATION

Learn more about the clinical data.

Provider Website
  • Dosing & Administration Guide
jublia

JUBLIA® (efinaconazole) Topical Solution, 10%

FULL PRESCRIBING
INFORMATION

See the clinical profile for JUBLIA and view the dosing video for proper application guidance.

Provider Website
siliq

SILIQ® (brodalumab) Injection 

FULL PRESCRIBING
INFORMATION

Please see full Prescribing Information, including Boxed Warning about suicidal behavior and ideation.

Explore helpful resources including a sample Letter of Medical Necessity, REMS program details, and SILIQ certification.

Provider Website
Letter of Medical Necessity
Get siliq certified
  • SILIQ REMS Program

Patient Savings Programs

Details on the Instant Savings and Patient Assistance programs, offering eligible patients financial support and access options.

lEARN mORE

Stay Informed

Stay informed with the latest news, resources, and treatment information delivered directly to your inbox

DUOBRII UPDATES Cabtreo Updates ARAZLO Updates

newsletter signup

newsletter signup

Ortho Dermatologics greatly respects your privacy and will never sell, rent, lease, or give away your information (name, address, email, etc.) to any third party. By submitting your information you confirm you have read and agree with our Privacy Policy.

Ortho Dermatologics greatly respects your privacy and will never sell, rent, lease, or give away your information (name, address, email, etc.) to any third party. By submitting your information you confirm you have read and agree with our Privacy Policy.

Products

  • All Products

resources

  • Resource Hub
  • Provider Resources
  • Patient Resources
  • Support & Savings
  • Derm Locator  

Conditions

  • Featured conditions

About

  • Who we are
  • Careers
  • Responsibility
  • Location
banner  

Newsletter sign up

  • Privacy Policy
  • Cookies Policy
  • Cookie Settings
  • Legal Notice
  • Site Map

CALIFORNIA RESIDENTS: DO NOT SELL MY PERSONAL INFORMATION ORD.0036.USA.25

  • .
  • ORD.0036.USA.25

XERESE is a registered trademark of Meda Pharma S.A.R.L. used under license. All other ®/TM are trademarks of Ortho Dermatologics or its affiliates.

© 2025 Ortho Dermatologics or its affiliates.